Chemed Corp. (CHE): are the analysts right?

Chemed Corp. · Health Care · ref. ETF XLV · 50 calls · price $458.18
What the company does: Chemed fournit des services de soins palliatifs et d'hospice par un réseau de professionnels de santé aux États-Unis.
📈 1-year price
$485.37+4.2% over range
Jul 8, 25low $368.59 · high $489.66Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 3 analysts

🎯 Analyst price target on CHE

High target · 1 analyst$500+9.1%
Median target · 3 analysts$475+3.7%
Low target · 1 analyst$436-4.8%
Current price$458.18

🗳️ The analyst consensus

Analyst breakdown · 3 (6 months)
Strong Buy0%
Buy33%
Hold67%
Sell0%
Strong Sell0%

💰 Chemed Corp. dividend

0.50%annual yield
📈 Steady dividend17 yrs of consecutive dividend increases
That's ~$2.40 per share per year.

✅ Historical analyst reliability on CHE

Most reliable analysts on CHE (% profitable · 365j · ≥2 calls)
Oppenheimer 73% +6.5% 11
RBC Capital 60% -1.0% 15

📊 What $1,000 invested in Chemed Corp. would be worth

In short — $1,000 invested in Chemed Corp. 10 years ago would be worth $3,319 today, i.e. +13%/yr on average. Best year: 2017 (+57%), worst: 2025 (-24%). Price performance, excluding dividends.

If I'd invested $1,000 in Chemed Corp.

InvestmentWorth todayGain
1 years ago$829-17%
3 years ago$922-8%
5 years ago$899-10%
10 years ago$3,319+232%
since inception (1984)$30,920+2992%

Return by year (Chemed Corp.)

YearReturn$1,000 invested at year start
2026 (YTD)+9%$1,090 (+9%)
2025-24%$829 (-17%)
2024-5%$786 (-21%)
2023+17%$922 (-8%)
2022+8%$993 (-1%)
2021-9%$899 (-10%)
2020+11%$997 (0%)
2019+57%$1,563 (+56%)
2018+14%$1,787 (+79%)
2017+57%$2,804 (+180%)
2016+18%$3,319 (+232%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on CHE

RBC Capital
Apr 27, 26
■ Sector Perform neutral · not a buy · 🎯$436
Price at call : $421.1 — gap to target +4%
Today : $458.18 — gap to target -5%
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Apr 27, 27
RBC Capital
Feb 27, 26
■ Sector Perform neutral · not a buy · 🎯$422
Price at call : $421.4 — gap to target +0%
Today : $458.18 — gap to target -8%
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Feb 27, 27
Oppenheimer
Feb 27, 26
▲ Outperform · 🎯$500
Price at call : $421.4 — upside +19%
Today : $458.18 — upside +9%
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
in progress (365j)
matures : Feb 27, 27
Jefferies
Jan 22, 26
■ Hold neutral · not a buy · 🎯$475
Price at call : $444.74 — gap to target +7%
Today : $458.18 — gap to target +4%
🎯 on CHE : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)
in progress (365j)
matures : Jan 22, 27
RBC Capital
Nov 10, 25
▲ Outperform · 🎯$572
Price at call : $445.53 — upside +28%
Today : $458.18 — upside +25%
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Nov 10, 26
▲ Buy · 🎯$595
Price at call : $457.89 — upside +30%
Today : $458.18 — upside +30%
🎯 on CHE : 100% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Sep 10, 26
Jefferies
Sep 2, 25
▲ Buy · 🎯$550
Price at call : $464 — upside +19%
Today : $458.18 — upside +20%
🎯 on CHE : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)
in progress (365j)
matures : Sep 2, 26
RBC Capital
Jul 31, 25
▲ Outperform · 🎯$589
Price at call : $417.85 — upside +41%
Today : $458.18 — upside +29%
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Jul 31, 26
Oppenheimer
Jul 31, 25
▲ Outperform · 🎯$580
Price at call : $412.3 — upside +41%
Today : $458.18 — upside +27%
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
in progress (365j)
matures : Jul 31, 26
Jefferies
Jul 25, 25
■ Hold neutral · not a buy · 🎯$500
Price at call : $470.72 — gap to target +6%
Today : $458.18 — gap to target +9%
🎯 on CHE : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)
in progress (365j)
matures : Jul 25, 26
RBC Capital
Jun 30, 25
▲ Outperform · 🎯$640
Price at call : $483.92 — upside +32%
Today : $458.18 — upside +40%
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Jun 30, 26
▲ Buy · 🎯$650
Price at call : $486.93 — upside +33%
Today : $458.18 — upside +42%
🎯 on CHE : 100% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Jun 30, 26
RBC Capital
Apr 28, 25
▲ Outperform · 🎯$674
Price at call : $574.96 — upside +17%
Today : $458.18 — upside +47%
Expected +17% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-26.3%
stock -26% · XLV +3%
RBC Capital
Mar 14, 25
▲ Outperform · 🎯$667
Price at call : $608.07 — upside +10%
Today : $458.18 — upside +46%
Expected +10% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-34.5%
stock -34% · XLV +3%
RBC Capital
Nov 5, 24
▲ Outperform · 🎯$633
Price at call : $549.99 — upside +15%
Today : $458.18 — upside +38%
Expected +15% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-21.7%
stock -22% · XLV -1%
RBC Capital
May 21, 24
▲ Outperform · 🎯$697
Price at call : $558.12 — upside +25%
Today : $458.18 — upside +52%
Expected +25% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+0.6%
stock +1% · XLV -11%
RBC Capital
Mar 4, 24
▲ Outperform · 🎯$712
Price at call : $636.72 — upside +12%
Today : $458.18 — upside +55%
Expected +12% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-6.5%
stock -7% · XLV +3%
Oppenheimer
Feb 29, 24
▲ Outperform · 🎯$650
Price at call : $613.81 — upside +6%
Today : $458.18 — upside +42%
Expected +6% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
-3.7%
stock -4% · XLV +2%
Oppenheimer
Jan 17, 24
▲ Outperform · 🎯$625
Price at call : $593.06 — upside +5%
Today : $458.18 — upside +36%
Expected +5% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
-6.5%
stock -6% · XLV +1%
RBC Capital
Oct 30, 23
▲ Outperform · 🎯$604
Price at call : $562.65 — upside +7%
Today : $458.18 — upside +32%
Expected +7% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-4.8%
stock -5% · XLV +19%
RBC Capital
Jul 31, 23
▲ Outperform · 🎯$576
Price at call : $520.99 — upside +11%
Today : $458.18 — upside +26%
Expected +11% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+9.4%
stock +9% · XLV +12%
Oppenheimer
Jul 27, 23
▲ Outperform · 🎯$590
Price at call : $523.21 — upside +13%
Today : $458.18 — upside +29%
Expected +13% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+6.0%
stock +6% · XLV +11%
RBC Capital
May 1, 23
▲ Outperform · 🎯$610
Price at call : $552.96 — upside +10%
Today : $458.18 — upside +33%
Expected +10% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+2.7%
stock +3% · XLV +5%
Oppenheimer
Apr 28, 23
▲ Outperform · 🎯$610
Price at call : $552.96 — upside +10%
Today : $458.18 — upside +33%
Expected +10% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+2.5%
stock +2% · XLV +5%
RBC Capital
Feb 27, 23
▲ Outperform · 🎯$587
Price at call : $535.55 — upside +10%
Today : $458.18 — upside +28%
Expected +10% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+11.4%
stock +11% · XLV +15%
RBC Capital
Nov 3, 22
▲ Outperform · 🎯$545
Price at call : $481.1 — upside +13%
Today : $458.18 — upside +19%
Expected +13% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+21.1%
stock +21% · XLV -2%
RBC Capital
Aug 1, 22
▲ Outperform · 🎯$541
Price at call : $470.28 — upside +15%
Today : $458.18 — upside +18%
Expected +15% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+10.8%
stock +11% · XLV +2%
RBC Capital
Apr 28, 22
▲ Outperform · 🎯$592
Price at call : $499.51 — upside +19%
Today : $458.18 — upside +29%
Expected +19% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+10.4%
stock +10% · XLV -0%
RBC Capital
Mar 4, 22
▲ Outperform · 🎯$579
Price at call : $485.9 — upside +19%
Today : $458.18 — upside +26%
Expected +19% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+6.2%
stock +6% · XLV -3%
RBC Capital
Jul 29, 21
▲ Outperform · 🎯$609
Price at call : $476.02 — upside +28%
Today : $458.18 — upside +33%
Expected +28% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-1.2%
stock -1% · XLV -1%
Oppenheimer
Feb 25, 21
▲ Outperform · 🎯$580
Price at call : $445.21 — upside +30%
Today : $458.18 — upside +27%
Expected +30% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+7.4%
stock +7% · XLV +15%
RBC Capital
Mar 11, 20
▲ Outperform · 🎯$535
Price at call : $414.05 — upside +29%
Today : $458.18 — upside +17%
Expected +29% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
+7.0%
stock +7% · XLV +25%
Oppenheimer
Feb 19, 20
▲ Outperform · 🎯$535
Price at call : $487.26 — upside +10%
Today : $458.18 — upside +17%
Expected +10% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
-0.2%
stock -0% · XLV +11%
Oppenheimer
Nov 25, 19
■ Perform neutral · not a buy · 🎯$470
Price at call : $427.75 — gap to target +10%
Today : $458.18 — gap to target +3%
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
in progress (365j)
matures : Nov 24, 20
▲ Market Outperform · 🎯$490
Price at call : $411.17 — upside +19%
Today : $458.18 — upside +7%
Expected +19% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on CHE : 100% (1 call matured) · 📊 unranked overall
+17.1%
stock +17% · XLV +9%
RBC Capital
Feb 25, 19
■ Sector Perform neutral · not a buy · 🎯$318
Price at call : $326.45 — gap to target -3%
Today : $458.18 — gap to target -31%
🎯 on CHE : 60% (15 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Feb 25, 20
▲ Buy · 🎯$390
Price at call : $303.24 — upside +29%
Today : $458.18 — upside -15%
Expected +29% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on CHE : 100% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)
+35.9%
stock +36% · XLV -1%
Oppenheimer
Oct 27, 17
▲ Outperform · 🎯$225
Price at call : $222.65 — upside +1%
Today : $458.18 — upside -51%
Expected +1% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+25.2%
stock +25% · XLV +8%
Keybanc
Aug 28, 17
■ Sector Weight neutral · not a buy
🎯 on CHE : no call matured yet · 📊 on Health : 33.3% · -8.8% (42 calls)
in progress (365j)
matures : Aug 28, 18
Oppenheimer
Sep 22, 15
▲ Outperform · 🎯$150
Price at call : $138.13 — upside +9%
Today : $458.18 — upside -67%
Expected +9% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+1.2%
stock +1% · XLV +5%
Oppenheimer
Apr 29, 15
▲ Outperform · 🎯$130
Price at call : $117.82 — upside +10%
Today : $458.18 — upside -72%
Expected +10% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+11.8%
stock +12% · XLV -3%
■ Hold neutral · not a buy · 🎯$75
Price at call : $83.95 — gap to target -11%
Today : $458.18 — gap to target -84%
🎯 on CHE : no call matured yet · 📊 on Health : 51.3% · +8.7% (76 calls)
in progress (365j)
matures : May 1, 15
Deutsche Bank
Oct 30, 13
■ Hold neutral · not a buy · 🎯$64
Price at call : $66.82 — gap to target -4%
Today : $458.18 — gap to target -86%
🎯 on CHE : no call matured yet · 📊 on Health : 51.3% · +8.7% (76 calls)
in progress (365j)
matures : Oct 30, 14
Deutsche Bank
Sep 10, 13
■ Hold neutral · not a buy · 🎯$63
Price at call : $66.04 — gap to target -5%
Today : $458.18 — gap to target -86%
🎯 on CHE : no call matured yet · 📊 on Health : 51.3% · +8.7% (76 calls)
in progress (365j)
matures : Sep 10, 14
CL King
Jul 19, 13
■ Neutral neutral · not a buy
🎯 on CHE : 0% (1 call matured) · 📊 unranked overall
in progress (365j)
matures : Jul 19, 14
Oppenheimer
Jun 11, 13
▲ Outperform · 🎯$85
Price at call : $72 — upside +18%
Today : $458.18 — upside -81%
Expected +18% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+25.1%
stock +25% · XLV +25%
Deutsche Bank
Apr 19, 13
■ Hold neutral · not a buy · 🎯$80
Price at call : $78.7 — gap to target +2%
Today : $458.18 — gap to target -83%
🎯 on CHE : no call matured yet · 📊 on Health : 51.3% · +8.7% (76 calls)
in progress (365j)
matures : Apr 19, 14
CL King
Oct 31, 12
▲ Buy
Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 0% (1 call matured) · 📊 unranked overall
-1.7%
stock -2% · XLV +32%
Deutsche Bank
Oct 31, 12
■ Hold neutral · not a buy · 🎯$70
Price at call : $67.25 — gap to target +4%
Today : $458.18 — gap to target -85%
🎯 on CHE : no call matured yet · 📊 on Health : 51.3% · +8.7% (76 calls)
in progress (365j)
matures : Oct 31, 13
Oppenheimer
Oct 3, 12
▲ Outperform · 🎯$80
Price at call : $70.09 — upside +14%
Today : $458.18 — upside -83%
Expected +14% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on CHE : 73% (11 calls matureds) · 📊 on Health : 52.9% · +4.5% (68 calls)
+2.6%
stock +3% · XLV +24%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)